Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers

Lung Cancer

Volumn 72, Issue 3, 2011, Pages 280-286

  Lo, Yen Li ^a   Hsiao, Chin Fu ^a   Jou, Yuh Shan ^b   Chang, Gee Chen ^c   Tsai, Ying Huang ^d   Su, Wu Chou ^e   Chen, Kuan Yu ^f   Chen, Yuh Min ^g   Huang, Ming Shyan ^h   Hsieh, Wan Shan ^a   Chen, Chien Jen ⁱ   Hsiung, Chao A ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

^h KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

ⁱ GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Case control study; Environmental tobacco smoke; Gene environment interaction; Lung cancer; Mismatch repair; MLH1; MSH2; Never smokers

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; TOBACCO SMOKE POLLUTION;

EID: 79955482586     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.10.009     Document Type: Article

References (50)

1. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97:1407-1427.
2. Mattson M.E., Pollack E.S., Cullen J.W. What are the odds that smoking will kill you?. Am J Public Health 1987, 77:425-431.
3. Shields P.G., Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000, 18:2309-2315.
4. Shields P.G. Molecular epidemiology of smoking and lung cancer. Oncogene 2002, 21:6870-6876.
5. Kawajiri K., Nakachi K., Imai K., Watanabe J., Hayashi S. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 1993, 14:1085-1089.
6. Kim J.H., Kim H., Lee K.Y., Choe K.H., Ryu J.S., Yoon H.I., et al. Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. Hum Mol Genet 2006, 15:1181-1186.
7. Hung R.J., Brennan P., Canzian F., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005, 97:567-576.
8. Kunkel T.A., Erie D.A. DNA mismatch repair. Annu Rev Biochem 2005, 74:681-710.
9. Buermeyer A.B., Deschenes S.M., Baker S.M., Liskay R.M. Mammalian DNA mismatch repair. Annu Rev Genet 1999, 33:533-564.
10. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003, 21:1174-1179.
11. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 2006, 7:335-346.
12. Christmann M., Tomicic M.T., Roos W.P., Kaina B. Mechanisms of human DNA repair: an update. Toxicology 2003, 193:3-34.
13. Xinarianos G., Liloglou T., Prime W., Maloney P., Callaghan J., Fielding P., et al. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res 2000, 60:4216-4221.
14. Hsu H.S., Wen C.K., Tang Y.A., Lin R.K., Li W.Y., Hsu W.H., et al. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer. Clin Cancer Res 2005, 11:5410-5416.
15. Renkonen E., Zhang Y., Lohi H., Salovaara R., Abdel-Rahman W.M., Nilbert M., et al. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 2003, 21:3629-3637.
16. Park S.H., Lee G.Y., Jeon H.S., Lee S.J., Kim K.M., Jang S.S., et al. -93G-->A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer 2004, 112:678-682.
17. Yu J.H., Bigler J., Whitton J., Potter J.D., Ulrich C.M. Mismatch repair polymorphisms and colorectal polyps: hMLH1 -93G>A variant modifies risk associated with smoking. Am J Gastroenterol 2006, 101:1313-1319.
18. Chen H., Taylor N.P., Sotamaa K.M., Mutch D.G., Powell M.A., Schmidt A.P., et al. Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer 2007, 120:1684-1688.
19. Chang C.H., Hsiao C.F., Chang G.C., Tsai Y.H., Chen Y.M., Huang M.S., et al. Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan. Am J Epidemiol 2009, 170:695-702.
20. Chen K.Y., Hsiao C.F., Chang G.C., Tsai Y.H., Su W.C., Perng R.P., et al. Hormone replacement therapy and lung cancer risk in Chinese. Cancer 2007, 110:1768-1775.
21. Jou Y.S., Lo Y.L., Hsiao C.F., Chang G.C., Tsai Y.H., Su W.C., et al. Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients. Lung Cancer 2009, 64:251-256.
22. Lo Y.L., Jou Y.S., Hsiao C.F., Chang G.C., Tsai Y.H., Su W.C., et al. A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2009, 18:223-229.
23. Lo Y.-L., Hsiao C.-F., Jou Y.-S., Chang G.-C., Tsai Y.-H., Su W.-C., et al. ATM polymorphisms and risk of lung cancer among never smokers. Lung Cancer 2010, 69:148-154.
24. Sham P.C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995, 59:97-105.
25. Lewontin R.C. The interaction of selection and linkage II. Optimum models. Genetics 1964, 50:757-782.
26. Excoffier L., Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995, 12:921-927.
27. Wallenstein S., Hodge S.E., Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 1998, 15:173-181.
28. Gorlova O.Y., Zhang Y., Schabath M.B., Lei L., Zhang Q., Amos C.I., et al. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer 2006, 118:1798-1804.
29. Vineis P., Airoldi L., Veglia P., Olgiati L., Pastorelli R., Autrup H., et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. Bmj 2005, 330:277.
30. Boffetta P., Agudo A., Ahrens W., Benhamou E., Benhamou S., Darby S.C., et al. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998, 90:1440-1450.
31. Ito E., Yanagisawa Y., Iwahashi Y., Suzuki Y., Nagasaki H., Akiyama Y., et al. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun 1999, 256:488-494.
32. Wang Y.C., Lu Y.P., Tseng R.C., Lin R.K., Chang J.W., Chen J.T., et al. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest 2003, 111:887-895.
33. Safar A.M., Spencer H., Su X., Coffey M., Cooney C.A., Ratnasinghe L.D., et al. Methylation profiling of archived non-small cell lung cancer: a promising prognostic system. Clin Cancer Res 2005, 11:4400-4405.
34. Goldsborough A.S., Kornberg T.B. Reduction of transcription by homologue asynapsis in Drosophila imaginal discs. Nature 1996, 381:807-810.
35. Ianzano L., Zhao X.C., Minassian B.A., Scherer S.W. Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product. Genomics 2003, 81:579-587.
36. De Vivo I., Hankinson S.E., Colditz G.A., Hunter D.J. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res 2003, 63:5236-5238.
37. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
38. Thun M.J., Henley S.J., Burns D., Jemal A., Shanks T.G., Calle E.E. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006, 98:691-699.
39. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
40. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007, 7:778-790.
41. Gazdar A.F., Shigematsu H., Herz J., Minna J.D. Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?. Trends Mol Med 2004, 10:481-486.
42. Tomonaga T., Matsushita K., Ishibashi M., Nezu M., Shimada H., Ochiai T., et al. Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy. Cancer Res 2005, 65:4683-4689.
43. Benachenhou N., Guiral S., Gorska-Flipot I., Labuda D., Sinnett D. High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small cell lung cancer. Int J Cancer 1998, 77:173-180.
44. Hardman R.A., Afshari C.A., Barrett J.C. Involvement of mammalian MLH1 in the apoptotic response to peroxide-induced oxidative stress. Cancer Res 2001, 61:1392-1397.
45. Tse L.A., Yu I.T., Au J.S., Yu K.S., Kwok K.P., Qiu H., et al. Environmental tobacco smoke and lung cancer among Chinese nonsmoking males: might adenocarcinoma be the culprit?. Am J Epidemiol 2009, 169:533-541.
46. Nakachi K., Imai K., Hayashi S., Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993, 53:2994-2999.
47. Vineis P., Bartsch H., Caporaso N., Harrington A.M., Kadlubar F.F., Landi M.T., et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994, 369:154-156.
48. Kato S., Bowman E.D., Harrington A.M., Blomeke B., Shields P.G. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst 1995, 87:902-907.
49. An Y., Jin G., Wang H., Wang Y., Liu H., Li R., et al. Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population. Lung Cancer 2008, 59:164-170.
50. Yang H.C., Lin C.H., Hsu C.L., Hung S.I., Wu J.Y., Pan W.H., et al. A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. J Biomed Sci 2006, 13:489-498.